V体育平台登录 - Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
- PMID: 20962613
- PMCID: "V体育官网入口" PMC3154092
- DOI: 10.1097/QAD.0b013e328340a239
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Abstract
Objectives: Sustained suppression of plasma viremia in HIV-infected individuals is attainable with antiretroviral therapy (ART); however, eradication of virus that would allow discontinuation of ART has been hampered by the persistence of HIV reservoirs. It is of great interest to identify individuals who had received ART for prolonged periods of time with extremely low or undetectable HIV reservoirs and monitor plasma viremia following discontinuation of therapy. VSports手机版.
Methods: We measured the size of HIV reservoirs in CD4(+) T cells of individuals on long-term ART and monitored plasma viremia following cessation of ART in one individual with an exceptionally low viral burden after a decade of therapy V体育安卓版. .
Results: We demonstrated undetectable levels of HIV DNA in the blood of eight of 45 infected individuals on long-term ART. Among those eight individuals, the frequency of cells carrying infectious virus was significantly lower in those who initiated ART during the early versus the chronic phase of infection V体育ios版. One individual with undetectable HIV DNA in both blood and tissue and a profoundly low level of infectious virus experienced plasma viral rebound 50 days following discontinuation of ART. .
Conclusions: Our data suggest that a significant reduction in the size of viral reservoirs may be achievable in selected individuals who initiate standard ART early in infection. However, given re-emergence of plasma viremia in an individual with an extraordinarily low viral burden, therapeutic strategies aimed at specifically targeting these extremely rare HIV-infected cells with novel interventions may be necessary in order to achieve eradication of virus. VSports最新版本.
VSports - Conflict of interest statement
Potential conflicts of interest: A. C V体育平台登录. C. has received research grants from Boehringer-Ingelheim, Hoffman-La Roche, Gilead Sciences, Schering-Plough, and Tibotec-Virco, and consulted for Glaxo-Smith-Kline, Tibotec-Virco, and Pfizer.
Figures
Comment in
-
V体育平台登录 - Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.AIDS. 2011 Mar 27;25(6):871-2; author reply 872-3. doi: 10.1097/QAD.0b013e32834490b1. AIDS. 2011. PMID: 21412062 No abstract available.
"VSports app下载" References
-
- Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11–19. - PubMed
-
- Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 1997;94:13193–13197. - VSports最新版本 - PMC - PubMed
-
- Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278:1295–1300. - "VSports在线直播" PubMed
-
- Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278:1291–1295. - "V体育官网" PubMed
-
- Chun TW, Nickle DC, Justement JS, Meyers JH, Roby G, Hallahan CW, et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis. 2008;197:714–720. - PubMed
Publication types
MeSH terms
- "V体育官网入口" Actions
- Actions (VSports在线直播)
- VSports注册入口 - Actions
- Actions (V体育安卓版)
- Actions (VSports)
- "V体育安卓版" Actions
- VSports注册入口 - Actions
Substances
Grants and funding
LinkOut - more resources
V体育2025版 - Full Text Sources
Other Literature Sources
Medical
Research Materials (V体育ios版)
